Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Amryt Pharma plc (LSE: AMYT)

 
AMYT Technical Analysis
5
As on 10th Jan 2022 AMYT STOCK Price closed @ 143.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 190.41 & Strong Sell for SHORT-TERM with Stoploss of 201.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AMYTSTOCK Price

Open 155.00 Change Price %
High 155.00 1 Day -19.00 -11.73
Low 143.00 1 Week -4.50 -3.05
Close 143.00 1 Month -5.50 -3.70
Volume 90627 1 Year -63.00 -30.58
52 Week High 223.00 | 52 Week Low 138.00
 
LSE UK Most Active Stocks
DKE 0.15 0.00%
NNN 0.09 50.00%
SYME 0.10 -9.09%
DMTR 0.03 0.00%
PREM 0.53 3.92%
MCLS 1.68 46.09%
YGEN 0.49 0.00%
CLON 0.11 0.00%
VOD 71.04 0.57%
BOIL 0.10 0.00%
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
STM 47.50 72.73%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
AMYT
Daily Charts		 AMYT
Intraday Charts		 Whats New @
Bazaartrend		 AMYT
Free Analysis
 
AMYT Important Levels Intraday
RESISTANCE166.12
RESISTANCE158.71
RESISTANCE154.12
RESISTANCE149.54
SUPPORT136.46
SUPPORT131.88
SUPPORT127.29
SUPPORT119.88
 
AMYT Forecast May 2024
Share
4th UP Forecast187.32
3rd UP Forecast173.11
2nd UP Forecast164.32
1st UP Forecast155.54
1st DOWN Forecast130.47
2nd DOWN Forecast121.68
3rd DOWN Forecast112.89
4th DOWN Forecast98.68
 
AMYT Weekly Forecast
4th UP Forecast181.54
3rd UP Forecast169.18
2nd UP Forecast161.54
1st UP Forecast153.90
1st DOWN Forecast132.10
2nd DOWN Forecast124.46
3rd DOWN Forecast116.82
4th DOWN Forecast104.46
 
AMYT Forecast2024
4th UP Forecast412.97
3rd UP Forecast326.39
2nd UP Forecast272.87
1st UP Forecast219.35
1st DOWN Forecast66.65
2nd DOWN Forecast13.13
3rd DOWN Forecast-40.39
4th DOWN Forecast-126.97
 
 
AMYT Other Details
Segment EQ
Market Capital 507047968.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
AMYT Address
AMYT
 
AMYT Latest News
 
Your Comments and Response on Amryt Pharma plc
 
AMYT Business Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland. Address: 45 Mespil Road, Dublin, Ireland, 4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service